Phase 1 First-in-Human Study of JNJ-95566692 in Participants with NHLs
95566692LYM1001
Phase 1 other active
Quick answer
Phase 1 First-in-Human Study of JNJ-95566692 in Participants with NHLs for Non-Hodgkin Lymphoid Malignancies (NHLs) is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Non-Hodgkin Lymphoid Malignancies (NHLs)
- Phase
- Phase 1
- Modality
- other
- Status
- active